Oric Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ORIC

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

50,782

Value ($000)

415

Weight

0.0%

2020 Q2 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	415	0.0%	50,782	12/31/2025
2025 Q3	11/14/2025	279	0.0%	23,235	9/30/2025
2025 Q1	5/19/2025	2,841	0.0%	509,179	3/31/2025
2024 Q4	2/14/2025	287	0.0%	35,579	12/31/2024
2024 Q3	11/14/2024	236	0.0%	23,034	9/30/2024
2024 Q2	8/14/2024	299	0.0%	42,320	6/30/2024
2022 Q1	5/16/2022	70	0.0%	13,033	3/31/2022
2021 Q4	2/14/2022	192	0.0%	13,033	12/31/2021
2021 Q3	11/15/2021	273	0.0%	13,033	9/30/2021
2021 Q2	8/16/2021	231	0.0%	13,033	6/30/2021
2021 Q1	5/14/2021	270	0.0%	11,000	3/31/2021
2020 Q4	3/1/2021	250	0.0%	7,400	12/31/2020
2020 Q2	8/14/2020	431	0.0%	12,775	6/30/2020